Substance P enhances the therapeutic effect of MSCs by modulating their angiogenic potential

Bone marrow mesenchymal stem cell (MSC) therapy acts through multiple differentiations in damaged tissue or via secretion of paracrine factors, as demonstrated in various inflammatory and ischaemic diseases. However, long‐term ex vivo culture to obtain a sufficient number of cells in MSC transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Hyun Sook, Kim, Suna, Jin, Yinji, Son, Youngsook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687016/
https://www.ncbi.nlm.nih.gov/pubmed/32985796
http://dx.doi.org/10.1111/jcmm.15804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687016/
https://www.ncbi.nlm.nih.gov/pubmed/32985796
http://dx.doi.org/10.1111/jcmm.15804

Ejemplares similares